SALAROGLIO, Iris Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.286
EU - Europa 1.675
AS - Asia 1.232
AF - Africa 33
SA - Sud America 19
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.260
Nazione #
US - Stati Uniti d'America 2.203
CN - Cina 792
IT - Italia 616
SE - Svezia 182
IE - Irlanda 164
AT - Austria 156
FR - Francia 122
HK - Hong Kong 100
DE - Germania 85
GB - Regno Unito 70
SG - Singapore 63
JP - Giappone 60
UA - Ucraina 54
CA - Canada 48
PL - Polonia 48
TW - Taiwan 46
VN - Vietnam 36
MX - Messico 35
IN - India 34
FI - Finlandia 29
KR - Corea 26
BE - Belgio 24
ES - Italia 20
TR - Turchia 17
DK - Danimarca 16
NL - Olanda 16
GR - Grecia 13
AU - Australia 12
IR - Iran 12
RU - Federazione Russa 12
CH - Svizzera 11
EG - Egitto 11
PT - Portogallo 10
SN - Senegal 9
BR - Brasile 8
NO - Norvegia 8
HU - Ungheria 7
ID - Indonesia 6
MA - Marocco 6
RO - Romania 6
TH - Thailandia 6
AM - Armenia 4
AR - Argentina 4
BD - Bangladesh 4
CL - Cile 4
IQ - Iraq 4
MY - Malesia 4
UZ - Uzbekistan 4
MO - Macao, regione amministrativa speciale della Cina 3
PH - Filippine 3
EC - Ecuador 2
IL - Israele 2
MD - Moldavia 2
MU - Mauritius 2
NG - Nigeria 2
PK - Pakistan 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CO - Colombia 1
EU - Europa 1
JO - Giordania 1
LV - Lettonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TN - Tunisia 1
Totale 5.260
Città #
Chandler 252
Torino 206
Beijing 179
Fairfield 166
Ashburn 160
Dublin 160
Vienna 154
Houston 113
Woodbridge 99
Ann Arbor 94
Wilmington 77
Seattle 73
Turin 72
Dearborn 64
Cambridge 61
Nyköping 58
New York 49
Guangzhou 48
Pisa 48
Redwood City 44
Princeton 38
Central 37
Shanghai 37
Taipei 34
Medford 31
Fremont 29
Nanjing 28
Villeurbanne 28
Hangzhou 27
Warsaw 26
Changsha 24
Jacksonville 23
Boston 19
Milan 19
Dong Ket 18
London 18
Wuhan 18
Brussels 17
Paris 16
Boardman 15
San Diego 15
Shenzhen 15
Toronto 15
San Jose 14
Los Angeles 13
Tokyo 13
Xian 13
Shenyang 12
Buffalo 11
Chengdu 11
Helsinki 11
Jinan 11
Singapore 11
Tianjin 11
Brescia 10
Central District 10
Rome 10
Seoul 10
Chicago 9
Hebei 9
Ottawa 9
Changchun 8
Fuzhou 8
Hefei 8
San Francisco 8
Suzhou 8
Chongqing 7
Istanbul 7
Kunming 7
Mexico 7
San Giuliano Milanese 7
Silver Spring 7
Barcelona 6
Bethesda 6
Camporosso 6
Hamburg 6
Heidelberg 6
Hong Kong 6
Kharkiv 6
Lexington 6
Mumbai 6
Piemonte 6
Tappahannock 6
Xiamen 6
Angers 5
Athens 5
Birmingham 5
Bordeaux 5
Budapest 5
Changzhou 5
Dalian 5
Dallas 5
Duncan 5
Essen 5
Jakarta 5
Montreal 5
Nanning 5
North Point 5
Nottingham 5
San Mateo 5
Totale 3.156
Nome #
Impact of cancer metabolism on therapy resistance – Clinical implications 482
Hypoxia as a driver of resistance to immunotherapy 468
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 451
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 290
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 246
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy 242
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 238
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma 224
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 207
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 161
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 151
The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. 137
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma 137
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer 126
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment 122
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells 120
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 118
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 103
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 102
P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors 102
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro 101
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells 97
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 95
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 77
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 77
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 70
GIFC-2018 - BOOK OF ABSTRACTS 68
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 67
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells 65
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 65
Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation 61
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma 59
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 58
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 56
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma 55
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression 22
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer 21
Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells 19
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer 19
Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors 13
Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models 6
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma 2
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition 1
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs 1
Totale 5.402
Categoria #
all - tutte 13.146
article - articoli 0
book - libri 0
conference - conferenze 1.014
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019190 0 0 0 0 0 0 0 0 0 58 87 45
2019/2020661 22 17 28 51 41 83 81 65 71 77 64 61
2020/2021789 35 75 47 65 83 72 51 57 60 85 84 75
2021/2022742 54 31 34 90 30 33 41 43 33 62 167 124
2022/20231.175 92 74 51 92 117 205 98 100 139 54 60 93
2023/20241.023 115 129 92 104 82 160 125 88 38 90 0 0
Totale 5.402